Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC marketing for minimum of five years should enable monograph eligibility consideration.

This article was originally published in The Tan Sheet

Executive Summary

OTC MARKETING FOR MINIMUM OF FIVE YEARS EXPECTED TO SATISFY "MATERIAL TIME" requirements of the law relating to the consideration of new conditions of use for monograph eligibility, FDA said in an Oct. 3 Federal Register notice. Published in the form of an advanced notice of proposed rulemaking, the document tentatively concludes that the five-year minimum would apply to products marketed both in and outside the U.S.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086203

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel